Mr. Wei Xiang, Managing Director of Anrate expressed with joy: "On the occasion of Anrate's tenth anniversary, we are very pleased to have a comprehensive and in-depth cooperation with Körber, whose solutions have unique innovative awareness and industry's best practice experience. We look forward to leveraging the complementary strengths of both parties to provide strong technical support for Anrate's development."
As a leading representative of the biopharmaceutical industry, Anrate has always regarded digital and intelligent construction as one of the company's core strategies. The signing of this strategic cooperation agreement will enable Anrate to leverage Körber's continuous technological innovation and solutions since 1895 in the pharmaceutical industry to further enhance the company's smart factory level and manufacturing efficiency.
"Technology-assisted is the future direction of pharmaceutical development. Our solutions not only focus on the factory level but also take into account the special requirements of regulatory agencies and the pharmaceutical industry itself," said Mr. Jerry Zheng, Managing Director China of Körber Business Area, "We are firmly convinced that together we can further establish the concept of the "Factory of Excellence" in the pharmaceutical industry and thus create a technological breakthrough that will stand for efficiency and future orientation."
The signing of this strategic agreement is an important step for Anrate towards smart manufacturing and also another important investment by Körber in the Chinese market. "New Quality Productivity" is a new goal of industrial manufacturing advocated by the Chinese government. Körber and Anrate will work together to achieve intelligence, efficiency, and green production in the biopharmaceutical industry, and strive to set an example of smart manufacturing in the Chinese pharmaceutical industry.
No comments:
Post a Comment